发明名称 |
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND DIMETHYL FUMARATE. |
摘要 |
<p>This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with DMF. This invention also provides a package comprising laquinimod and DMF for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with DMF in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides a pharmaceutical composition comprising laquinimod and DMF for use in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and DMF in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.</p> |
申请公布号 |
MX2014011616(A) |
申请公布日期 |
2014.10.17 |
申请号 |
MX20140011616 |
申请日期 |
2013.03.26 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
KAYE JOEL FLAXMAN |
分类号 |
A61K31/4704 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|